Alan Van Goethem

1.6k total citations
8 papers, 178 citations indexed

About

Alan Van Goethem is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Alan Van Goethem has authored 8 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Cancer Research. Recurrent topics in Alan Van Goethem's work include Neuroblastoma Research and Treatments (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related Molecular Pathways (4 papers). Alan Van Goethem is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related Molecular Pathways (4 papers). Alan Van Goethem collaborates with scholars based in Belgium and United States. Alan Van Goethem's co-authors include Jo Vandesompele, Ali Rihani, Tom Van Maerken, Pieter Mestdagh, Maté Ongenaert, Pieter‐Jan Volders, Frank Speleman, Jason M. Shohet, Fjoralba Zeka and Steve Lefever and has published in prestigious journals such as Scientific Reports, Cancer Letters and Oncotarget.

In The Last Decade

Alan Van Goethem

8 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Van Goethem Belgium 5 135 101 39 32 10 8 178
Richard Y. Ebright United States 4 157 1.2× 118 1.2× 45 1.2× 54 1.7× 18 1.8× 5 215
Eleanor M. O’Brien United Kingdom 5 84 0.6× 39 0.4× 25 0.6× 21 0.7× 5 0.5× 6 107
Andrés Quintero Colombia 5 107 0.8× 83 0.8× 37 0.9× 103 3.2× 18 1.8× 6 232
Roberto Dinami Italy 7 251 1.9× 150 1.5× 31 0.8× 5 0.2× 17 1.7× 9 313
Alexandra T. Tankka United States 5 240 1.8× 82 0.8× 35 0.9× 10 0.3× 28 2.8× 5 282
Brian Gudenas United States 6 191 1.4× 142 1.4× 13 0.3× 20 0.6× 7 0.7× 12 223
Sydney M. Moyer United States 7 119 0.9× 38 0.4× 86 2.2× 6 0.2× 7 0.7× 8 162
Viktoria Marquardt Germany 5 94 0.7× 39 0.4× 35 0.9× 20 0.6× 10 1.0× 8 138
Francesco Tabaro Italy 7 258 1.9× 50 0.5× 18 0.5× 9 0.3× 7 0.7× 11 294
Diana Pickert Germany 2 305 2.3× 15 0.1× 92 2.4× 28 0.9× 5 0.5× 3 327

Countries citing papers authored by Alan Van Goethem

Since Specialization
Citations

This map shows the geographic impact of Alan Van Goethem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Van Goethem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Van Goethem more than expected).

Fields of papers citing papers by Alan Van Goethem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Van Goethem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Van Goethem. The network helps show where Alan Van Goethem may publish in the future.

Co-authorship network of co-authors of Alan Van Goethem

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Van Goethem. A scholar is included among the top collaborators of Alan Van Goethem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Van Goethem. Alan Van Goethem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2023). Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation. NAR Cancer. 5(1). zcad002–zcad002. 3 indexed citations
2.
Goethem, Alan Van, Pieter Mestdagh, Tom Van Maerken, & Jo Vandesompele. (2017). MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based Validation. Methods in molecular biology. 1654. 197–208. 1 indexed citations
3.
Goethem, Alan Van, Nurten Yigit, Myrthala Moreno‐Smith, et al.. (2017). Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma. Oncotarget. 8(34). 57047–57057. 26 indexed citations
4.
Goethem, Alan Van, Nurten Yigit, Celine Everaert, et al.. (2016). Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples. Scientific Reports. 6(1). 37876–37876. 11 indexed citations
5.
Rihani, Ali, Alan Van Goethem, Maté Ongenaert, et al.. (2015). Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma. Scientific Reports. 5(1). 9027–9027. 31 indexed citations
6.
Peer, Gert Van, Steve Lefever, Jasper Anckaert, et al.. (2014). miRBase Tracker: keeping track of microRNA annotation changes. Database. 2014. 69 indexed citations
7.
Maerken, Tom Van, Ali Rihani, Alan Van Goethem, et al.. (2013). Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer. Cancer Letters. 344(2). 157–165. 36 indexed citations
8.
Maerken, Tom Van, Ali Rihani, Alan Van Goethem, et al.. (2013). Selective inhibition of the p53–MDM2 interaction by nutlin drugs: a new therapeutic perspective for neuroblastoma. Ghent University Academic Bibliography (Ghent University). 2. 198–207. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026